Literature DB >> 9672373

Early identification of biliary pancreatitis with procalcitonin.

F M Brunkhorst, O K Eberhard, R Brunkhorst.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672373     DOI: 10.1111/j.1572-0241.1998.01191.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis.

Authors:  R Pezzilli; G V Melzi d'Eril; A M Morselli-Labate; G Merlini; B Barakat; T Bosoni
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

2.  Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.

Authors:  F M Brunkhorst; K Wegscheider; Z F Forycki; R Brunkhorst
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

Review 3.  Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.

Authors:  Philipp Schuetz; Werner Albrich; Beat Mueller
Journal:  BMC Med       Date:  2011-09-22       Impact factor: 8.775

4.  Inflammatory mediators in the diagnosis and treatment of acute pancreatitis: pentraxin-3, procalcitonin and myeloperoxidase.

Authors:  Osman Simsek; Ahmet Kocael; Pınar Kocael; Anıl Orhan; Mahir Cengiz; Huriye Balcı; Kenan Ulualp; Hafize Uzun
Journal:  Arch Med Sci       Date:  2018-02-21       Impact factor: 3.318

5.  Evaluation of Prognostic Factors of Severity in Acute Biliary Pancreatitis.

Authors:  Pedro Silva-Vaz; Ana Margarida Abrantes; Sara Morgado-Nunes; Miguel Castelo-Branco; António Gouveia; Maria Filomena Botelho; José Guilherme Tralhão
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

Review 6.  [Procalcitonin in the intensive care unit : Differential diagnostic and differential therapeutic possibilities].

Authors:  S Großmann; S Schroll; M Pfeifer
Journal:  Med Klin Intensivmed Notfmed       Date:  2020-06-29       Impact factor: 0.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.